Inventor · disambiguated record
Peter Hammerman
Also filed as: HAMMERMAN PETER
5 granted patents·3 pending applications·5 citations·filing 2013–2020
67Inventor score
Top patents by PatentIndex Score
8 records- 0189US10702527B2Combination therapy of transcription inhibitors and kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 7, 2020·5 cites·26 claims
- 0265US9499856B2DDR2 mutations in squamous cell lung cancerBROAD INST INC·Filed 2013·Granted Nov 22, 2016·0 cites·24 claims
- 0365US2020087734A1DDR2 Mutations in Squamous Cell Lung CancerBROAD INST INC·Filed 2019·Application pending·0 cites
- 0461US10385403B2DDR2 mutations in squamous cell lung cancerBROAD INST INC·Filed 2016·Granted Aug 20, 2019·0 cites·12 claims
- 0560US11926874B2Methods for identification, assessment, prevention, and treatment of cancer using PD-L1 isoformsDANA FARBER CANCER INST INC·Filed 2019·Granted Mar 12, 2024·0 cites·12 claims
- 0658US2020338074A1Combination therapy of transcription inhibitors and kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0747US2016122829A1Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 IsoformsDANA FARBER CANCER INST INC·Filed 2014·Application pending·0 cites
- 0842US11624093B2Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor responseDANA FARBER CANCER INST INC·Filed 2015·Granted Apr 11, 2023·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Peter Hammerman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →